Supplementary Figure S1: Effect of ipilimumab on immune subsets in human melanoma from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3&lt;sup&gt;+&lt;/sup&gt; Regulatory T Cells (Tregs) in Human Cancers